ENDRA Life Sciences (NDRA) Construction in Progress (2019 - 2024)
ENDRA Life Sciences (NDRA) reported Construction in Progress of $125153.0 for Q3 2024, down 11.0% year-over-year from $140617.0 in Q4 2023, and little changed quarter-over-quarter from $125151.0 in Q2 2024.
ENDRA Life Sciences (NDRA) Construction in Progress (2019 - 2024) Analysis & Trends
ENDRA Life Sciences (NDRA) has 6 years of Construction in Progress data on file, last reported at $125153.0 in Q3 2024.
- Construction in Progress for Q3 2024 came in at $125153.0, down 11.0% year-over-year; the trailing twelve-month figure through Sep 2024 was $125153.0 (down 11.0% YoY), and the FY2023 annual result was $125151.0, down 11.0% from the prior year.
- Construction in Progress steadied at $125153.0 in Q3 2024 per NDRA's latest filing, from $125151.0 in the prior quarter.
- Over five years, Construction in Progress peaked at $143482.0 in Q2 2022 and troughed at $79207.0 in Q4 2020.
- A 5-year average of $126508.4 and a median of $125153.0 in 2024 frame the typical range for Construction in Progress.
- The sharpest annual moves came in 2020 and 2023: Construction in Progress surged 81.68% in 2020, then retreated 11.0% in 2023.
- A 5-year view of Construction in Progress shows it stood at $79207.0 in 2020, then soared by 35.95% to $107682.0 in 2021, then jumped by 30.59% to $140617.0 in 2022, then retreated by 11.0% to $125151.0 in 2023, then advanced by 0.0% to $125153.0 in 2024.
- Business Quant data shows NDRA's Construction in Progress at $125153.0 in Q3 2024, $125151.0 in Q2 2024, and $125151.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 125,153.00 |
| Jun 30, 2024 | 125,151.00 |
| Mar 31, 2024 | 125,151.00 |
| Dec 31, 2023 | 125,151.00 |
| Sep 30, 2023 | 140,617.00 |
| Jun 30, 2023 | 140,617.00 |
| Mar 31, 2023 | 140,617.00 |
| Dec 31, 2022 | 140,617.00 |
| Sep 30, 2022 | 143,482.00 |
| Jun 30, 2022 | 143,482.00 |
| Mar 31, 2022 | 107,682.00 |
| Dec 31, 2021 | 107,682.00 |
| Dec 31, 2020 | 79,207.00 |
| Dec 31, 2019 | 43,596.00 |